A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS) | MicrobiomeTrials
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2021-11-17Est. Completion: 2025-07-04
Enrollment target: 41 participants
Locations
Children's Hospital Colorado, Aurora, Colorado, United States
University of Nebraska, Omaha, Nebraska, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
UZ Gent, Ghent, Belgium
UZ Leuven Gasthuisberg, Leuven, Belgium
Inst. Da Criança- Faculdade de Medicina Usp, São Paulo, São Paulo, Brazil
CHU Sainte-Justine, Montreal, Quebec, Canada
Peking University First Hospital, Beijing, China
Beijing Children's Hospital, Capital Medical University, Beijing, China
The children's hospital , Zhejiang university school of medicine, Hangzhou, China
Hôpital Arnaud de Villeneuve, Montpellier, France
Gh Necker Enfants Malades, Paris, France
Institute of Kidney Diseases and Research Centre, Ahmedabad, Gujarat, India
Medanta-The Medicity, Gurgaon, Haryana, India
All India Institute Of Medical Sciences (AIIMS), New Delhi, National Capital Territory of Delhi, India
Aichi Children?s Health and Medical Center, Aichi, Japan
Chiba Children's Hospital, Chibashi, Chibaken, Japan
Other microbiome trials you might be interested in